Measuring Efficacy of an Oral-Irrigator After Three Weeks of Use

Gingivitis Clinical Trial

Official title:

An Experimental Clinical Study to Assess the Gingivitis and Plaque Reduction Efficacy of an Oral-Irrigator After Three Weeks of Use

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04899440
• Other study ID #: 2021043
• Status: Completed
• Start date: June 3, 2021
• Est. completion date: June 24, 2021

Study information

• Verified date: July 2022
• Source: Procter and Gamble
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The primary objective of this exploratory study is to evaluate the efficacy of an Oral Irrigator in the reduction of gingivitis compared to a negative control over a 3 week period by using the Modified Gingival Index and the Gingival Bleeding Index. The secondary objective is to evaluate the efficacy of an Oral Irrigator in the reduction of plaque compared to a negative control using the extended Turesky Modified Quigley-Hein Index (TQHPI) after 3 weeks of use.

Description:

This is a single-center, examiner-blind, three (3) week, two (2) treatment, parallel group, randomized study design. Thirty (30) subjects who have shown evidence of gingivitis and plaque will be enrolled in this study. Subjects will be evaluated for gingivitis using the Modified Gingival Index (MGI) and the Gingival Bleeding Index (GBI) and evaluated for plaque using the Turesky Modified Quigley-Hein Plaque Index (TQHPI) at two (2) time points: Baseline and after three (3) weeks of product use. Qualified subjects will be stratified and randomly assigned to one of the two treatment groups, toothbrushing on conjunction with an Oral Irrigator or toothbrushing without an Oral Irrigator (N=15/treatment). Subjects will be instructed to brush twice a day for approximately three (3) weeks with their assigned products and return for plaque and gingivitis measures at approximately three (3) weeks after the Baseline visit.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: June 24, 2021
• Est. primary completion date: June 24, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Give written informed consent and receive a copy of the signed Informed Consent form;

• Be at least 18 years of age;

• Typically use a manual toothbrush;

• Be in good general health as determined by the investigator/designee based on a review/update of their medical history;

• Possess a minimum of 16 scorable teeth (excluding third molars) with facial and lingual scorable surfaces;

• Have a Baseline MGI score between 1.75 and 2.5;

• Have a Baseline TQHPI score of at least 2.00;

• Have a Baseline between 20 and 80 Bleeding sites;

• Abstained from all oral hygiene procedures for approximately 12 hours prior to this visit and agree to do the same prior to the subsequent visit;

• Abstained from eating, drinking*, chewing gum and using tobacco for at least 4 hours prior to this visit and agree to do the same prior to the subsequent visit. *(Exception: Allowed small sips of water up until 45 minutes prior to their appointment time.)

• Agree not to participate in any other oral care study for the duration of this study;

• Agree to delay any elective dentistry, including dental prophylaxis, and to report any non-study dentistry received during the course of this study;

• Agree to refrain from using any non-study toothbrushes, dentifrices, mouth rinses, tooth whitening products or floss for the study duration; and

• Agree to return for their scheduled visits and to follow all study procedures.

Exclusion Criteria:

• Hypersensitivity to dyes;

• Severe periodontal disease, as characterized by purulent exudate, generalized mobility, and/or severe recession;

• Any carious lesions requiring restorative treatment;

• Active treatment for periodontitis;

• Any fixed facial orthodontic appliances or retainers;

• Use of any antibiotic medication or a prescription mouth rinse any time within the 2 weeks prior to study initiation; or

• Any disease or conditions that could be expected to interfere with examination; procedures or the subject safely completing the study.

Related Conditions & MeSH terms

• Gingivitis
• Plaque

Intervention

Device:
• Water Flosser
A pressurized stream of water to reduce gingivitis and remove adherent plaque

Other:
• Control
No Oral Irrigator Control

Locations

Country	Name	City	State
United States	Salus Research	Fort Wayne	Indiana

Sponsors (1)

Lead Sponsor	Collaborator
Procter and Gamble

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	MGI-Modified Gingival Index	Modified Gingival Index score after 3 weeks of product use. Gingivitis will be scored on the buccal and lingual marginal gingival and interdental papilla of all scorable teeth (six scores per tooth):0 = normal (absence of inflammation); 1 = mild inflammation (slight change of color, little change in texture) of any portion of the gingival unit; 2 = mild inflammation of the entire gingival unit; 3 = moderate inflammation (moderate glazing, redness, edema and/or hypertrophy) of the gingival unit; 4 = severe inflammation (marked redness and edema/hypertrophy, spontaneous bleeding or ulceration) of the gingival unit. MGI whole mouth score is computed by summing the scores and dividing by the number of scorable sites examined.	MGI Score after 3 weeks of product use.
Primary	GBI-Gingival Bleeding Index	Gingival Bleeding Index score after 3 weeks of product use. Each of the 3 gingival areas, i.e., buccal, mesial/dystal and lingual, of the teeth will be probed in this manner waiting approximately 30 seconds before recording the number of gingival units which bleed, according to the following scale: 0 = absence of bleeding after 30 seconds; 1 = bleeding observed after 30 seconds; 2 = immediate bleeding observed. GBI whole mouth score is computed by summing the scores and dividing by the number of scorable sites examined.	GBI score after 3 weeks of product use.
Secondary	Plaque- TMQHP	Turesky Modified Quigley-Hein Plaque Index score after 3 weeks of product use. The plaque deposits on the buccal, lingual, and whole mouth average plaque scores will be calculated for each subject and tooth surfaces by totaling the scores and dividing by the number of gradable sites examined. Scoring criteria are shown below. 0=No Plaque; 1=Separate flecks of plaque at the cervical margin; 2=A thin, continuous band of plaque (up to 1 mm) at the cervical margin; 3=A band of plaque wider than 1mm, but covering less than one third of the side of the crown of the tooth; 4=Plaque covering at least one third, but less than two thirds of the side of the crown of the tooth; 5=Plaque covering two thirds or more of the side of the crown of the tooth; 8=Ungradable site; 9=Missing tooth	TMQHP score after 3 weeks of product use.